Tracking cancer medication safety with a self-monitoring platform
Part of Cancer, Digestive system, Kidney & urinary, Lungs & breathing, Skin clinical trials.
This trial tests a platform where you can track your experiences and concerns about cancer medications. It aims to help you and your care team manage medication safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have lung, colorectal, breast, or prostate cancer
- You are currently receiving active cancer treatment
- You take one or more cancer medications on your own
- You have a smartphone, tablet, or computer to use the platform (or a family member can help you)
- You speak and read English (or have a family member or friend who can assist you)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether patients in early-phase cancer trials can comfortably use smartwatches and phone apps to track their health and report how they're feeling. The goal is to see if these tools can help doctors better understand how cancer treatments affect daily life.
This trial tests whether combining regular medication safety checks with electronic tracking of side effects can improve quality of life and help reduce economic burden for people taking cancer pills. It’s for people starting oral cancer therapy and using connected technology to report symptoms.
This study tests whether a smartphone app (Caaring®) can help monitor cancer patients who take oral medications. If you are on an oral cancer treatment and comfortable using a smartphone, this trial may help you stay connected with your care team and manage side effects from home.
This trial tests whether using a smartphone app to report symptoms helps patients feel better and manage side effects during cancer treatment. If you have cancer at any stage and are on systemic therapy, you may be able to join.
This study compares a digital health monitoring platform (Cureety Techcare) to standard care for people with metastatic triple-negative breast cancer who are starting their first treatment. The goal is to see if using the platform helps manage symptoms and improve quality of life.
This study tests whether wearing a smartwatch and using an app can help doctors better manage pain and other symptoms in advanced cancer patients. The goal is to catch problems early and improve comfort through better symptom tracking.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.